GRAL
GRAIL, LLC
NASDAQ: GRAL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$54.48
+9.64% today
Updated 2026-04-30
Market cap
$2.14B
P/E ratio
—
P/S ratio
14.55x
EPS (TTM)
$-11.11
Dividend yield
—
52W range
$30 – $119
Volume
1.4M
GRAIL, LLC (GRAL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-209.26M | $-245.79M | $-232.00M | $-688.13M | $-561.31M | $-595.80M | $-577.16M | $-299.01M |
| Capital expenditures | $15.99M | $3.33M | $11.90M | $69.93M | $22.86M | $12.89M | $5.21M | $909000.00 |
| Depreciation | $14.08M | $10.31M | $7.56M | $58.45M | $154.76M | $158.70M | $158.06M | — |
| Stock-based comp | $11.04M | $28.39M | $45.99M | $681.91M | $75.73M | $97.23M | $86.08M | $58.28M |
| Free cash flow | $-225.25M | $-249.13M | $-243.91M | $-758.06M | $-584.17M | $-608.69M | $-582.36M | $-299.92M |
| Investing cash flow | $-93.39M | $133.04M | $-12.79M | $344.81M | $-22.86M | $-12.89M | $-551.01M | $-85.05M |
| Financing cash flow | $300.62M | $160.33M | $275.11M | $394.74M | $604.82M | $463.77M | $1.24B | $423.32M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |